捷邦科技(301326.SZ):在東莞市已形成年產2萬噸碳納米管導電漿料的成熟產線,可基本滿足目前業務發展需求
格隆匯4月12日丨捷邦科技(301326.SZ)在投資者互動平台表示,公司在東莞市已形成年產2萬噸碳納米管導電漿料的成熟產線,可基本滿足目前業務發展需求。具體產能數據詳見公司2023年年度報吿。此外,公司子公司瑞泰新材與江安縣人民政府於2022年4月19日簽訂了《江安縣年產5000噸碳納米管和3.6萬噸CNT導電漿料投資協議書》及補充協議,約定瑞泰新材在江安縣投資建設“年產5000噸碳納米管和3.6萬噸CNT導電漿料項目”,目前該項目正依照客户需求及公司經營情況進行推進。關於公司客户拓展情況,公司目前已經取得寧德時代、比亞迪、億緯鋰能、孚能科技、正力新能、鵬輝能源、多氟多等客户的合格供應商代碼;部分客户已實現量產交貨,寧德時代已開始少量交貨,比亞迪根據項目及產品的不同,處於產品驗證或商務談判階段,尚未量產供貨。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.